aquatest suspensie injectabila 50 mg/ml
balkan pharmaceuticals srl, sc - testosteronum - suspensie injectabila - 50 mg/ml
proscar 5 mg
merck sharp & dohme bv - olanda - finasteridum - compr. film. - 5mg - medicamente pt.tratamentul hipertrofiei benigne de prostata inhibitori de testosteron 5-alpha reductaza
lutrate depot 22,5 mg
gp-pharm s.a. - spania - leuprorelinum - pulb+solv. pt. susp. inj. cu elib. prel. - 22,5mg - hormoni si substante inrudite analogi de gonado relina
lutrate depot 22,5 mg
gp-pharm s.a. - spania - leuprorelinum - pulb.+solv. pt. susp. inj. cu elib. prel. - 22,5mg - hormoni si substante inrudite analogi de gonado relina
proscar 5 mg
merck sharp & dohme bv - olanda - finasteridum - compr. film. - 5mg - medicamente pt.tratamentul hipertrofiei benigne de prostata inhibitori de testosteron 5-alpha reductaza
eligard 22,5 mg
astellas pharma europe b.v. - olanda - leuprorelinum - pulb+solv. pt. sol. inj. - 22,5mg - hormoni si substante inrudite analogi de gonadorelina
eligard 45 mg
astellas pharma europe bv - olanda - leuprorelinum - pulb+solv.pt.sol.inj. - 45mg - hormoni si substante inrudite analogi de gonadorelina
eligard 22,5 mg
recordati industria chimica e farmaceutica s.p.a. - italia - leuprorelinum - pulb.+solv. pt. sol. inj. - 22,5mg - hormoni si substante inrudite analogi de gonadorelina
eligard 45 mg
recordati industria chimica e farmaceutica s.p.a. - olanda - leuprorelinum - pulb.+solv. pt. sol. inj. - 45mg - hormoni si substante inrudite analogi de gonadorelina
xtandi
astellas pharma europe b.v. - enzalutamide - prostate neoplasme - terapia endocrină - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.